Shenzhen Noposion Agrochemicals Co Ltd
SZSE:002215
Balance Sheet
Balance Sheet Decomposition
Shenzhen Noposion Agrochemicals Co Ltd
Current Assets | 5.3B |
Cash & Short-Term Investments | 1.4B |
Receivables | 1.7B |
Other Current Assets | 2.1B |
Non-Current Assets | 5.9B |
Long-Term Investments | 2.4B |
PP&E | 3B |
Intangibles | 277.8m |
Other Non-Current Assets | 188.4m |
Current Liabilities | 5.6B |
Accounts Payable | 497.5m |
Accrued Liabilities | 70.5m |
Short-Term Debt | 4.6B |
Other Current Liabilities | 435.8m |
Non-Current Liabilities | 1.7B |
Long-Term Debt | 907.9m |
Other Non-Current Liabilities | 815m |
Balance Sheet
Shenzhen Noposion Agrochemicals Co Ltd
Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||
Cash & Cash Equivalents |
652
|
668
|
634
|
573
|
597
|
810
|
718
|
731
|
1 202
|
1 036
|
|
Cash |
1
|
1
|
1
|
1
|
2
|
7
|
1
|
1
|
1 199
|
1 036
|
|
Cash Equivalents |
652
|
668
|
633
|
572
|
595
|
803
|
717
|
730
|
3
|
0
|
|
Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
357
|
342
|
260
|
157
|
|
Total Receivables |
169
|
250
|
244
|
237
|
734
|
1 109
|
1 039
|
919
|
929
|
1 121
|
|
Accounts Receivables |
128
|
206
|
171
|
146
|
584
|
859
|
755
|
676
|
576
|
735
|
|
Other Receivables |
42
|
44
|
74
|
91
|
150
|
250
|
284
|
243
|
353
|
386
|
|
Inventory |
381
|
425
|
349
|
477
|
933
|
1 212
|
1 141
|
1 161
|
1 281
|
1 067
|
|
Other Current Assets |
260
|
114
|
385
|
413
|
656
|
776
|
476
|
574
|
696
|
770
|
|
Total Current Assets |
1 463
|
1 457
|
1 612
|
1 700
|
2 920
|
3 907
|
3 731
|
3 725
|
4 368
|
4 151
|
|
PP&E Net |
266
|
264
|
263
|
270
|
328
|
398
|
530
|
654
|
1 485
|
2 494
|
|
PP&E Gross |
266
|
264
|
263
|
270
|
328
|
398
|
530
|
654
|
1 485
|
2 494
|
|
Accumulated Depreciation |
153
|
181
|
209
|
242
|
272
|
290
|
313
|
341
|
438
|
566
|
|
Intangible Assets |
108
|
103
|
156
|
212
|
299
|
335
|
282
|
239
|
251
|
220
|
|
Goodwill |
40
|
40
|
31
|
53
|
78
|
107
|
107
|
101
|
99
|
65
|
|
Long-Term Investments |
675
|
622
|
948
|
820
|
828
|
697
|
1 083
|
1 034
|
1 453
|
2 698
|
|
Other Long-Term Assets |
27
|
40
|
66
|
93
|
90
|
79
|
151
|
218
|
158
|
173
|
|
Other Assets |
40
|
40
|
31
|
53
|
78
|
107
|
107
|
101
|
99
|
65
|
|
Total Assets |
2 579
N/A
|
2 526
-2%
|
3 077
+22%
|
3 148
+2%
|
4 542
+44%
|
5 523
+22%
|
5 884
+7%
|
5 972
+1%
|
7 814
+31%
|
9 801
+25%
|
|
Liabilities | |||||||||||
Accounts Payable |
87
|
145
|
201
|
165
|
312
|
346
|
293
|
267
|
218
|
336
|
|
Accrued Liabilities |
107
|
102
|
106
|
98
|
123
|
142
|
137
|
145
|
170
|
188
|
|
Short-Term Debt |
484
|
325
|
184
|
537
|
1 292
|
1 600
|
1 825
|
1 596
|
2 380
|
3 325
|
|
Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
36
|
43
|
|
Other Current Liabilities |
360
|
355
|
787
|
559
|
502
|
641
|
675
|
856
|
957
|
848
|
|
Total Current Liabilities |
1 038
|
927
|
1 278
|
1 358
|
2 228
|
2 730
|
2 930
|
2 864
|
3 761
|
4 741
|
|
Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
25
|
320
|
556
|
|
Deferred Income Tax |
6
|
6
|
6
|
22
|
39
|
36
|
28
|
22
|
16
|
107
|
|
Minority Interest |
24
|
23
|
26
|
121
|
307
|
595
|
600
|
614
|
654
|
610
|
|
Other Liabilities |
35
|
26
|
25
|
27
|
30
|
29
|
47
|
96
|
97
|
118
|
|
Total Liabilities |
1 102
N/A
|
982
-11%
|
1 334
+36%
|
1 528
+15%
|
2 604
+70%
|
3 391
+30%
|
3 605
+6%
|
3 621
+0%
|
4 848
+34%
|
6 133
+27%
|
|
Equity | |||||||||||
Common Stock |
542
|
704
|
914
|
914
|
914
|
914
|
914
|
914
|
984
|
995
|
|
Retained Earnings |
529
|
617
|
778
|
411
|
722
|
917
|
1 155
|
1 190
|
1 409
|
1 544
|
|
Additional Paid In Capital |
409
|
234
|
58
|
297
|
304
|
308
|
308
|
318
|
627
|
708
|
|
Unrealized Security Profit/Loss |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
22
|
477
|
|
Treasury Stock |
3
|
10
|
7
|
0
|
0
|
0
|
101
|
56
|
32
|
56
|
|
Other Equity |
0
|
1
|
1
|
1
|
1
|
7
|
3
|
16
|
0
|
0
|
|
Total Equity |
1 476
N/A
|
1 544
+5%
|
1 743
+13%
|
1 621
-7%
|
1 939
+20%
|
2 132
+10%
|
2 279
+7%
|
2 351
+3%
|
2 966
+26%
|
3 668
+24%
|
|
Total Liabilities & Equity |
2 579
N/A
|
2 526
-2%
|
3 077
+22%
|
3 148
+2%
|
4 542
+44%
|
5 523
+22%
|
5 884
+7%
|
5 972
+1%
|
7 814
+31%
|
9 801
+25%
|
|
Shares Outstanding | |||||||||||
Common Shares Outstanding |
915
|
903
|
908
|
914
|
914
|
914
|
914
|
914
|
987
|
995
|